Odyssey Health, Inc.
Datakwaliteit: 83%
ODYY
OTC
Manufacturing
Measuring & Analyzing Instruments
€ 0,07
€ 0,00
(0,00%)
Marktkapitalisatie: 6,49 M
Prijs
€ 0,07
Marktkapitalisatie
6,49 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Negative free cash flow of -620.457,0
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio0,06
Interest Coverage-1,23
Waardering
PE (TTM)
-1,41
Boven sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1366 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1366 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -1,4 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -53,5 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
Geen toekomstige schattingen beschikbaar
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -4,59 M |
| ROE | N/A | ROA | -1061,07% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -620.457,0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,06 |
| Interest Coverage | -1,23 | Asset Turnover | N/A |
| Working Capital | -10,60 M | Tangible Book Value | -10,60 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1,41 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -9,56% | ||
| Market Cap | 6,49 M | Enterprise Value | 6,49 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,05 | Revenue / Share | N/A |
| FCF / Share | -0,01 | OCF / Share | -0,01 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 13,52% |
| SBC-Adj. FCF | -692.725 | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | 0,0 |
| Net Income | -1,74 M | -842.316,0 | -5,92 M | -8,44 M | -16,88 M |
| EPS (Diluted) | -0,02 | -0,01 | -0,07 | -0,09 | — |
| Gross Profit | — | — | — | — | 0,0 |
| Operating Income | -1,02 M | 14,26 M | -5,31 M | -8,11 M | -15,86 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 0,0 | — | — | — | 1,63 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | 1.538,0 | 3.416,0 | 2.374,0 | 5.552,0 |
| Interest Expense | 252.516,0 | 518.476,0 | 614.083,0 | 836.294,0 | 1,07 M |
| Income Tax | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 49.723,0 | 586.146,0 | 455.793,0 | 569.677,0 | 610.533,0 |
| Total Liabilities | — | — | — | — | 3,38 M |
| Shareholders' Equity | -6,95 M | -5,33 M | -6,16 M | -4,64 M | -2,77 M |
| Total Debt | — | — | — | — | 0,0 |
| Cash & Equivalents | — | — | 36.865,0 | 72.534,0 | 556.584,0 |
| Current Assets | 49.723,0 | 56.943,0 | 405.888,0 | 526.417,0 | 610.119,0 |
| Current Liabilities | 7,00 M | 5,92 M | 6,61 M | 5,21 M | 3,38 M |
{"event":"ticker_viewed","properties":{"ticker":"ODYY","listing_kind":"stock","pathname":"/stocks/odyy","exchange":"OTC","country":"US"}}